Global Recombinant Protein Reagents 麻豆原创 Research Report 2025

Publication ID:

PB503251417

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Recombinant Protein Reagents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Recombinant Protein Reagents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Protein Reagents is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Protein Reagents in Biopharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Protein Reagents include Abcam PLC, R&D Systems, Miltenyi Biotec, Merck KGaA, ThermoFisher Scientific, GE Healthcare, Lonza, Eurogentec (Kaneka Corporation), PeproTech, BPS Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Reagents.
The Recombinant Protein Reagents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Protein Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Protein Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abcam PLC
R&D Systems
Miltenyi Biotec
Merck KGaA
ThermoFisher Scientific
GE Healthcare
Lonza
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
Abnova Corporation
GenScript Biotech Corporation
ProSpec Tany TechnoGene
Novoprotein
Sino Biological
ACROBiosystems Group
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Recombinant Protein Reagents 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 麻豆原创 by Application
1.3.1 Global Recombinant Protein Reagents 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Protein Reagents 麻豆原创 Perspective (2020-2031)
2.2 Global Recombinant Protein Reagents Growth Trends by Region
2.2.1 Global Recombinant Protein Reagents 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Protein Reagents Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Recombinant Protein Reagents Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Recombinant Protein Reagents 麻豆原创 Dynamics
2.3.1 Recombinant Protein Reagents Industry Trends
2.3.2 Recombinant Protein Reagents 麻豆原创 Drivers
2.3.3 Recombinant Protein Reagents 麻豆原创 Challenges
2.3.4 Recombinant Protein Reagents 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Reagents Players by Revenue
3.1.1 Global Top Recombinant Protein Reagents Players by Revenue (2020-2025)
3.1.2 Global Recombinant Protein Reagents Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Recombinant Protein Reagents 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Protein Reagents Revenue
3.4 Global Recombinant Protein Reagents 麻豆原创 Concentration Ratio
3.4.1 Global Recombinant Protein Reagents 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Reagents Revenue in 2024
3.5 Global Key Players of Recombinant Protein Reagents Head office and Area Served
3.6 Global Key Players of Recombinant Protein Reagents, Product and Application
3.7 Global Key Players of Recombinant Protein Reagents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Protein Reagents Breakdown Data by Type
4.1 Global Recombinant Protein Reagents Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Recombinant Protein Reagents Forecasted 麻豆原创 Size by Type (2026-2031)
5 Recombinant Protein Reagents Breakdown Data by Application
5.1 Global Recombinant Protein Reagents Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Recombinant Protein Reagents Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Protein Reagents 麻豆原创 Size (2020-2031)
6.2 North America Recombinant Protein Reagents 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Protein Reagents 麻豆原创 Size by Country (2020-2025)
6.4 North America Recombinant Protein Reagents 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Protein Reagents 麻豆原创 Size (2020-2031)
7.2 Europe Recombinant Protein Reagents 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Protein Reagents 麻豆原创 Size by Country (2020-2025)
7.4 Europe Recombinant Protein Reagents 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Reagents 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Recombinant Protein Reagents 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Protein Reagents 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Protein Reagents 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Protein Reagents 麻豆原创 Size (2020-2031)
9.2 Latin America Recombinant Protein Reagents 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Protein Reagents 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Recombinant Protein Reagents 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Reagents 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Recombinant Protein Reagents 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Protein Reagents 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Protein Reagents 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam PLC
11.1.1 Abcam PLC Company Details
11.1.2 Abcam PLC Business Overview
11.1.3 Abcam PLC Recombinant Protein Reagents Introduction
11.1.4 Abcam PLC Revenue in Recombinant Protein Reagents Business (2020-2025)
11.1.5 Abcam PLC Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Recombinant Protein Reagents Introduction
11.2.4 R&D Systems Revenue in Recombinant Protein Reagents Business (2020-2025)
11.2.5 R&D Systems Recent Development
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Details
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec Recombinant Protein Reagents Introduction
11.3.4 Miltenyi Biotec Revenue in Recombinant Protein Reagents Business (2020-2025)
11.3.5 Miltenyi Biotec Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Recombinant Protein Reagents Introduction
11.4.4 Merck KGaA Revenue in Recombinant Protein Reagents Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 ThermoFisher Scientific
11.5.1 ThermoFisher Scientific Company Details
11.5.2 ThermoFisher Scientific Business Overview
11.5.3 ThermoFisher Scientific Recombinant Protein Reagents Introduction
11.5.4 ThermoFisher Scientific Revenue in Recombinant Protein Reagents Business (2020-2025)
11.5.5 ThermoFisher Scientific Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Recombinant Protein Reagents Introduction
11.6.4 GE Healthcare Revenue in Recombinant Protein Reagents Business (2020-2025)
11.6.5 GE Healthcare Recent Development
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza Recombinant Protein Reagents Introduction
11.7.4 Lonza Revenue in Recombinant Protein Reagents Business (2020-2025)
11.7.5 Lonza Recent Development
11.8 Eurogentec (Kaneka Corporation)
11.8.1 Eurogentec (Kaneka Corporation) Company Details
11.8.2 Eurogentec (Kaneka Corporation) Business Overview
11.8.3 Eurogentec (Kaneka Corporation) Recombinant Protein Reagents Introduction
11.8.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Protein Reagents Business (2020-2025)
11.8.5 Eurogentec (Kaneka Corporation) Recent Development
11.9 PeproTech
11.9.1 PeproTech Company Details
11.9.2 PeproTech Business Overview
11.9.3 PeproTech Recombinant Protein Reagents Introduction
11.9.4 PeproTech Revenue in Recombinant Protein Reagents Business (2020-2025)
11.9.5 PeproTech Recent Development
11.10 BPS Bioscience
11.10.1 BPS Bioscience Company Details
11.10.2 BPS Bioscience Business Overview
11.10.3 BPS Bioscience Recombinant Protein Reagents Introduction
11.10.4 BPS Bioscience Revenue in Recombinant Protein Reagents Business (2020-2025)
11.10.5 BPS Bioscience Recent Development
11.11 Reprocell
11.11.1 Reprocell Company Details
11.11.2 Reprocell Business Overview
11.11.3 Reprocell Recombinant Protein Reagents Introduction
11.11.4 Reprocell Revenue in Recombinant Protein Reagents Business (2020-2025)
11.11.5 Reprocell Recent Development
11.12 Abnova Corporation
11.12.1 Abnova Corporation Company Details
11.12.2 Abnova Corporation Business Overview
11.12.3 Abnova Corporation Recombinant Protein Reagents Introduction
11.12.4 Abnova Corporation Revenue in Recombinant Protein Reagents Business (2020-2025)
11.12.5 Abnova Corporation Recent Development
11.13 GenScript Biotech Corporation
11.13.1 GenScript Biotech Corporation Company Details
11.13.2 GenScript Biotech Corporation Business Overview
11.13.3 GenScript Biotech Corporation Recombinant Protein Reagents Introduction
11.13.4 GenScript Biotech Corporation Revenue in Recombinant Protein Reagents Business (2020-2025)
11.13.5 GenScript Biotech Corporation Recent Development
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Details
11.14.2 ProSpec Tany TechnoGene Business Overview
11.14.3 ProSpec Tany TechnoGene Recombinant Protein Reagents Introduction
11.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Protein Reagents Business (2020-2025)
11.14.5 ProSpec Tany TechnoGene Recent Development
11.15 Novoprotein
11.15.1 Novoprotein Company Details
11.15.2 Novoprotein Business Overview
11.15.3 Novoprotein Recombinant Protein Reagents Introduction
11.15.4 Novoprotein Revenue in Recombinant Protein Reagents Business (2020-2025)
11.15.5 Novoprotein Recent Development
11.16 Sino Biological
11.16.1 Sino Biological Company Details
11.16.2 Sino Biological Business Overview
11.16.3 Sino Biological Recombinant Protein Reagents Introduction
11.16.4 Sino Biological Revenue in Recombinant Protein Reagents Business (2020-2025)
11.16.5 Sino Biological Recent Development
11.17 ACROBiosystems Group
11.17.1 ACROBiosystems Group Company Details
11.17.2 ACROBiosystems Group Business Overview
11.17.3 ACROBiosystems Group Recombinant Protein Reagents Introduction
11.17.4 ACROBiosystems Group Revenue in Recombinant Protein Reagents Business (2020-2025)
11.17.5 ACROBiosystems Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Abcam PLC
R&D Systems
Miltenyi Biotec
Merck KGaA
ThermoFisher Scientific
GE Healthcare
Lonza
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
Abnova Corporation
GenScript Biotech Corporation
ProSpec Tany TechnoGene
Novoprotein
Sino Biological
ACROBiosystems Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.